In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
Kucukates
Emine
E
Nalan Karayel
Emine
E
Gultekin
Nazmi
N
Okuyan
Ertugrul
E
Kansiz
Erhan
E
Gurler
Nezahat
N
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002309:Cardiology; D003030:Coagulase / Q000378:metabolism; D024881:Drug Resistance, Bacterial; D013502:General Surgery; D006801:Humans; D007362:Intensive Care Units; D008826:Microbial Sensitivity Tests; D010068:Oxacillin / Q000494:pharmacology*; D013203:Staphylococcal Infections / Q000382:microbiology; D013210:Staphylococcus / Q000187:drug effects* / Q000201:enzymology / Q000302:isolation & purification; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D017334:Teicoplanin / Q000494:pharmacology*; D014640:Vancomycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D003030:Coagulase; D017334:Teicoplanin; D014640:Vancomycin; D010068:Oxacillin